Keith Denner Extends Current Technology's Chairman and C...(ctions in respect of his holdings that h...),Health
Navigation Links
Keith Denner Extends Current Technology's Chairman and CEO Options
Date:4/10/2008
ctions in respect of his holdings that he deems appropriate in light of the circumstances then existing, including the purchase of additional common shares or other securities of the Company through open market purchases or privately negotiated transactions, or the sale of all or a portion of his holdings in the open market or in privately negotiated transactions.
'/>"/>
| SOURCE Current Technology Corporation Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Atlanta Falcons Linebacker Keith Brooking Prepares to Run for Something Better at ING Georgia Marathon
2. Therap Services Welcomes Anna Keith to the US Customer Support Team
3. Viant Appoints Keith Vangeison as Executive Vice President of Network Development
4. Verus Pharmaceuticals Announces Promotion of Robert W. Keith to Chief Executive Officer
5. Keith Taft Named General Manager of UltraTape Industries
6. Parker Extends Precise Medical Seal Capability; Acquires Hi-Tech Group Companies
7. The Quantum Group Extends CEOs Employment Agreement
8. Hands on Disaster Response Extends Cyclone Relief Project
9. PROGNOSIS Extends its Popular IP Telephony Management Software to Support Nortel Environments
10. FDA Extends Review Timeline for Additional Indication for Antibiotic DORIBAX(TM)
11. Actavis Extends Portfolio With Four New Products in the U.S.
Post Your Comments:
(Date:10/6/2008)... NEW JERSEY, Oct. 6 /PRNewswire/ -- The organizer...gural conference on Global Sourcing for the,Pharma... 2008 at the,Princeton Marriott in New Jersey USA....sident & CEO of the,Global Sourcing Council, and b...rs including the likes of Johnson & Johnson, Brist...
(Date:10/6/2008)... LegalView recently posted ...tal regarding the potentially serious side effects...hibitors. Among the drug,s potential side effects ...-causing agents for young adult and child patients...tober 6, 2008 -- LegalView, the number one resourc...
(Date:10/6/2008)... Hospital Ship Serving in W... Garden Valley, Texas October 6, 200...e premier global provider of communications servic...s donated access to the FoxNews channel via satell...agship, the Africa Mercy. The Africa Mercy is the...
(Date:10/6/2008)... WALLDORF, Germany, Oct. 6 /PRNewswire-FirstCall/... Papandrea has joined SAP as senior vice president... position, effective,August 1, 2008, Mr. Papandrea... in providing strategic software solutions to heal...ement was made in conjunction,with the 3rd annual ...
Breaking Medicine News(10 mins):Health News:Global Sourcing Strategies for the Pharmaceutical Industry 10th - 11th November, Marriott Princeton, New Jersey USA 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 3Health News:Seamobile Provides Foxnews To Mercy Ships 2Health News:Seamobile Provides Foxnews To Mercy Ships 3Health News:SAP Appoints John Papandrea to Lead Healthcare Business Unit 2Health News:SAP Appoints John Papandrea to Lead Healthcare Business Unit 3[0] Global Sourcing Strategies for the Pharmaceutical Industry 10th - 11th November, Marriott Princeton, New Jersey USA[0] LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis[0] Seamobile Provides Foxnews To Mercy Ships [0] SAP Appoints John Papandrea to Lead Healthcare Business Unit
...s women who allow only short intervals of time bet...loping complications. Researchers in Scotland stud...between 1992 and 1998. Results of the study show w...ch more likely to become pregnant again in less th...
...mmonly used to lower cholesterol levels appear to ... unknown cause. The disease, known as idiopathic d...d heart that doesn't pump properly. Unlike the mos... due to a blockage of the coronary arteries that f...
... the majority of the public still does not know ch...e lives, the American Heart Association believes t...s. Their new study finds physicians, overall, need... disease is the leading cause of death in the Unit...
...eering fertility treatment 25 years ago, IVF has n...s born in the United States alone, according to th...is a procedure that involves retrieving the eggs f...th sperm from the father. The resulting embryo is ...
Other Medicine News:Health News:Test tube babies, 25 years later 2(Date:10/6/2008)... - Data Presented at ACG Annual Scientific C...- Ironwood Pharmaceuticals,(formerly Microbia) tod...reclinical studies delineating the role that cycli...ing intestinal pain. These studies,demonstrate tha...odel of,intestinal hyperalgesia and desensitizes c...
(Date:10/6/2008)... Results from Phase 3b Studies with Durezol Dosed .../ -- Sirion Therapeutics, Inc., a,privately held o...nced,today that Durezol(TM) (difluprednate ophthal... Durezol, which was approved by the U.S. Food and,...thalmic corticosteroid,indicated for the treatment...
(Date:10/6/2008)...More than 60 percent of moderate to severe patient...rcent achieved endoscopic remission at Week 10,in ...the American College,of Gastroenterology (ACG) Ann...Newswire/ -- UCB today presented data from a,large...vement in Crohn,s,disease (CD) with a biologic com...
(Date:10/6/2008)...SEATTLE, Oct. 6 /- Dendreon... call today, Monday, October 6, 2008 at 9:00 AM,ET... analysis of its IMPACT,(IMmunotherapy for Prostat...clinical trial of PROVENGE(R) (sipuleucel-T), the ...erapy for the treatment of advanced prostate,cance...
Breaking Medicine Technology:Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 2Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 2Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 2CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 3CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 6CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 7Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial 2TGen and Washington University researchers discover new approach to treating endometrial cancer 4660 1TGen and Washington University researchers discover new approach to treating endometrial cancer 4660 2TGen and Washington University researchers discover new approach to treating endometrial cancer 4660 3ICERx org Activated to Provide Emergency Access to Prescription Medication Information for Hurricane Gustav Evacuees 25915 1American Red Cross Relief Efforts Underway for Gustav 25910 1American Red Cross Relief Efforts Underway for Gustav 25910 2New master switch found in the brain that regulates appetite and reproduction 4655 1New master switch found in the brain that regulates appetite and reproduction 4655 2New master switch found in the brain that regulates appetite and reproduction 4655 3New master switch found in the brain that regulates appetite and reproduction 4655 4[1] Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain[0] Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain[0] CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients[0] Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial
...ire-FirstCall/ - Bradmer,Pharmaceuticals Inc., a b...ent and commercialization of cancer therapies, tod...ependent team in,Basel, Switzerland validates tena...lopment of new treatments for glioblastoma,multifo...oss of NOTCH2 gene,positively predicts survival in...
...2007 - AVI BioPharma, Inc.,(Nasdaq:AVII) announced... target patient enrollment and released six-month,...n as Appraisal.,The trial, currently being held in...Neugene(R) antisense drug Resten-MP(TM), when,used...bare metal,stents, in the prevention of cardiovasc...
Other Medicine Technology:Molecular Target of Bradmer's Neuradiab Further Validated by,Independent Findings 2Molecular Target of Bradmer's Neuradiab Further Validated by,Independent Findings 3Molecular Target of Bradmer's Neuradiab Further Validated by,Independent Findings 4AVI BioPharma Partner Cook Medical Announces Completion of Patient,Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of,Cardiovascular Disease 2Straight heavy shafts with delicate 7 mm tying platform. Sharp pointed tips for removing fine sutures. Wide serrated handle with polished finish. Overall length 4.1 inches.
Tying forceps with 6.5 mm tying platform. Round handle with flats provide flexibility of round handle with the stability of a flat handle. Curved shafts. Overall length 3.9 inches.
Delicate curved tying forcep with round handle is excellent for all fine suturing techniques. Useful for corneal transplants where delicate control is required.
Straight, 7 mm tying platform. Castroviejo handle. Manufactured in titanium. Overall length 4.2 inches.
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |